[The dynamics of the immune indices with the use of immunomudulin in patients with a mandibular fracture].
Forty-one patients with fractures of the lower jaw and 20 health donors have been examined. Patients with unilateral mandibular fractures received a conventional treatment (group 1) patients with bilateral mandibular fractures received a conventional treatment and immunomodulin (group 2). Results of investigations showed that immunity indices in patients of group 1 at admission to the hospital were in the normal limits, and reduced by the discharge. Immunity findings in patients of group 2 were rather decreased at admission, and normal after use of immunomodulin. Complications in group 2 were less frequent than in group 1.
Boĭmuradov
Sh A
ShA
Ubaĭdullaev
M B
MB
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D000293:Adolescent; D000328:Adult; D000818:Animals; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D007111:Immunity, Cellular / Q000187:drug effects; D008297:Male; D008337:Mandibular Fractures / Q000150:complications / Q000188:drug therapy* / Q000276:immunology; D009930:Organic Chemicals; D012756:Sheep; D013950:Thymus Gland; D013997:Time Factors; D014020:Tissue Extracts / Q000627:therapeutic use*
D000276:Adjuvants, Immunologic; D009930:Organic Chemicals; D014020:Tissue Extracts; C404023:immunomodulin